(Q42924910)

11 November 2017

title

Tauroursodeoxycholate counteracts hepatocellular lysis induced by tensioactive bile salts by preventing plasma membrane-micelle transition (English)

1 reference

11 November 2017

0 references

Cecilia L. Basiglio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797393

2 July 2024

Aldo D. Mottino

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797393

2 July 2024

Marcelo G. Roma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797393

2 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20797393

2 July 2024

publication date

24 August 2010

1 reference

full work available at URL

11 November 2017

https://api.elsevier.com/content/article/PII:S0009279710005193?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

https://api.elsevier.com/content/article/PII:S0009279710005193?httpAccept=text/plain

2 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Chemico-biological Interactions

2 July 2024

published in

1 reference

11 November 2017

volume

188

1 reference

11 November 2017

issue

3

1 reference

11 November 2017

page(s)

386-392

1 reference

Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Ursodeoxycholic acid treatment for chronic cholestatic liver disease

2 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Ursodeoxycholic acid in chronic liver disease

2 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children

2 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo

2 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis

2 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects

2 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Dynamic localization of hepatocellular transporters in health and disease.

2 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Ursodeoxycholic acid: Mechanism of action and novel clinical applications

2 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids.

2 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes

2 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Bile acids: regulation of apoptosis by ursodeoxycholic acid

2 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

2 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts.

2 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Ursodeoxycholate stabilizes phospholipid-rich membranes and mimics the effect of cholesterol: investigations on large unilamellar vesicles

2 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

The role of membrane cholesterol in determining bile acid cytotoxicity and cytoprotection of ursodeoxycholic acid

2 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Isolation and characterization of lipid microdomains from apical and basolateral plasma membranes of rat hepatocytes

2 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver

2 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Protein measurement with the Folin phenol reagent

2 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

The interaction of flavonoids with membranes: potential determinant of flavonoid antioxidant effects

2 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

A stability test of liposome preparations using steady-state fluorescent measurements

2 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study

2 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Signaling modulation of bile salt-induced necrosis in isolated rat hepatocytes

2 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Criteria of Viability of Isolated Liver Cells

2 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Liver protection by silymarin: in vitro effect on dissociated rat hepatocytes

2 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes

2 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria

2 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation

2 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Interactions of surfactants with lipid membranes

2 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Differential effects of silymarin and its active component silibinin on plasma membrane stability and hepatocellular lysis

2 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Cholesterol modulation of membrane resistance to Triton X-100 explored by atomic force microscopy

2 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Studies with digitonin-treated rat hepatocytes (nude cells)

2 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Interaction of digitonin and its analogs with membrane cholesterol

2 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

Development and validation of a method for measuring the glycine and taurine conjugates of bile acids in bile by high-performance liquid chromatography

2 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

The cholesterol-complexing agent digitonin modulates ligand binding of the bovine hippocampal serotonin 1A receptor

2 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CBI.2010.08.004

2 July 2024

Identifiers

1 reference

11 November 2017

1 reference